NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Name: NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Published: 2024
License: Public Domain

St. Jude Children's Research Hospital · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

adipocytic neoplasm, liposarcoma, atypical fibroxanthoma, angiomatoid fibrous histiocytoma, fibrosarcoma nos, myxofibrosarcoma, angiosarcoma, osteosarcoma, extraskeletal, dedifferentiated liposarcoma, myxoid liposarcoma, pleomorphic liposarcoma, myxoid pleomorphic liposarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1030665
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.